National HealthCare Corp. Hits New 52-Week High at $231.00

National HealthCare Corp. has reached a significant milestone by hitting a new 52-week high of USD 231.00 on July 28, 2026. This achievement underscores the company's strong performance in the hospital industry, particularly impressive given its small-cap status with a market capitalization of USD 2,503 million. Over the past year, National HealthCare Corp. has demonstrated remarkable growth, with a performance increase of 181.74%, significantly outpacing the S&P 500's 16.26% gain during the same period. The company's price-to-earnings (P/E) ratio stands at 21.00, reflecting its valuation in the market. Additionally, National HealthCare Corp. offers a dividend yield of 1.56%, which may appeal to income-focused investors. The company's financial health is further illustrated by a return on equity of 10.96% and a price-to-book ratio of 2.34. With a debt-to-equity ratio of -0.29, National HealthCare Corp. appears to maintain a solid balance sheet. This recent price achievement marks a notable point in the company's ongoing performance trajectory.